Clover Health Investments Corp.
CLOV evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for CLOV—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$2.63B
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Mar 31, 2026.
Tracking 3 clinical trials for Clover Health Investments Corp..
Run Clover Health Investments Corp. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available Clover Health Investments Corp. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
D/E 1.06
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
0 buys · 5 sells (180d)
Regulatory
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
209
Total value held
$261.5M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 33,964,146 | $59.8M |
| blackrock, inc. | 31,840,512 | $56.0M |
| geode capital management, llc | 10,055,510 | $17.7M |
| state street corp | 9,559,889 | $16.8M |
| charles schwab investment management inc | 5,300,475 | $9.3M |
| susquehanna international group, llp | 5,091,057 | $9.0M |
| pnc financial services group, inc. | 3,764,034 | $6.6M |
| vanguard portfolio management llc | 3,696,437 | $6.5M |
| dimensional fund advisors lp | 3,417,866 | $6.0M |
| renaissance technologies llc | 3,401,541 | $6.0M |
Showing top 10 of 209 institutional holders of Clover Health Investments Corp.. Open the full 13F history after sign-in.
Short Interest
as of May 20, 2026- % of float
- 9.4%
- Days to cover
- 6.8
- Shares short
- 39,092,575
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
CLOV short interestGovernance
Frequently asked questions
Who is the CEO of Clover Health Investments Corp.?
Mr. Andrew Toy is the chief executive officer of Clover Health Investments Corp. (CLOV).
Where is Clover Health Investments Corp. headquartered?
Clover Health Investments Corp. (CLOV) is headquartered in Wilmington, DE, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.